3Keulenaer G, Brutsaert D. Pathogenesis of heart failure changing conceptual paradigms. Acta Cardiol,1998,53:131-141. 被引量：1
4The Criteria Committee of New York Heart Association. 1994 revisions to classification of functional capacity and objective assessment of patients with disease of the heart. Circulation, 1994,90:644-645. 被引量：1
5Nagele H, Marlies Bahol, Rainer Klapdor, et al. CA125 and its relation to cardiac function. Am Heart J, 1999,137 : 1044-1049. 被引量：1
6Deleeuw PW,kroon AA. Hypertersion and the development of heart failure. Cardiovasc Pharmacol, 1998,32:9-15. 被引量：1
7[3]Kabawat SE, Bast RC Jr, Bhan AK, et al. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol, 1983, 2: 275-285. 被引量：1
8[4]Niloff JM, Knapp RC, Schaetzl E, et al. CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol, 1984, 64: 703-707. 被引量：1
9[5]Niloff JM, Klug TL, Schaetzl E, et al. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol, 1984, 148: 1057-1058. 被引量：1
10[6]Seo T, Ikeda Y, Onaka H, et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J, 1993, 57:489-494. 被引量：1
